Leaflet ATG-FRESENIUS 20mg / ml concentrate for solution for injection
Indicated for: prevention and treatment of transplant rejection
Route of administration: injectable
Substance: rabbit anti-human lymphocyte immunoglobulin (immunoglobulin)
ATC: L04AA04 (Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Rabbit anti-human lymphocyte immunoglobulin is used for the prevention and treatment of acute rejection in organ transplantation. It works by suppressing the body's immune response, reducing T-lymphocyte activity.
The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.
Side effects may include fever, chills, skin rashes, or injection site reactions. In rare cases, severe allergic reactions or opportunistic infections may occur.
Rabbit anti-human lymphocyte immunoglobulin is not recommended for patients with hypersensitivity to animal-derived proteins or active severe infections.
General data about ATG-FRESENIUS 20mg / ml
- Substance: rabbit anti-human lymphocyte immunoglobulin
- Date of latest medicines list: 01-07-2013
- Product code: W13440002
- Concentration: 20mg / ml
- Pharmaceutical form: concentrate for solution for injection
- Quantity: 10
- Product type: Generic medicine
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.